Nashville, TN — Nashville, Tennessee

Nashville, TN is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Nashville, TN has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Advanced Solid Tumors, Lymphoma, Diabetic Macular Edema (DME).

Sponsors: Agios Pharmaceuticals, Inc., EyeBiotech Ltd..

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nashville, TN?

Nashville, TN has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nashville, TN conducted?

Nashville, TN has 5 clinical trials on record, with 3 currently active. Their work covers Advanced Solid Tumors, Lymphoma, Diabetic Macular Edema (DME).

Is Nashville, TN accredited by Crixeo Health?

Nashville, TN has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nashville, TN?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.